Related Experiment Video
Updated: Jun 23, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Delay of adequate empiric antibiotic therapy is associated with increased mortality among solid-organ transplant
B Hamandi1, A M Holbrook, A Humar
1Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada. mailto:bassem.hamandi@uhn.on.ca
Abstract:
Empiric antibiotic therapy is often prescribed prior to the availability of bacterial culture results. In some cases, the organism isolated may not be susceptible to initial empiric therapy (inadequate empiric therapy or IET). In solid-organ transplant recipients, the overall incidence and clinical importance of IET is unknown. We performed a retrospective cohort study of patients admitted from 2002 to 2004. Multiple logistic regression analyses were conducted to determine associations between potential determinants and mortality. IET was administered in 169/312 (54%) patients, with a hospital mortality rate that was significantly greater than those receiving adequate therapy (24.9% vs. 7.0%; relative risk [RR] 3.55; 95% confidence interval [CI], 1.85-6.83; p < 0.001). Regression analysis demonstrated that an increasing duration of IET (adjusted odds ratio [OR] at 24 h: 1.33; 95% CI: 1.15-1.53; p < 0.001), ICU-associated infections (adjusted OR: 6.27; 95% CI: 2.79-14.09; p < 0.001), prior antibiotic use (adjusted OR: 3.56; 95% CI: 1.51-8.41; p = 0.004) and increasing APACHE-II scores (adjusted OR: 1.26; 95% CI: 1.16-1.34; p < 0.001) were independently correlated with hospital mortality. IET is common and appears to be associated with an increased hospital mortality rate in the solid-organ transplant population.
Insights
Inadequate empiric therapy (IET) is common in solid-organ transplant recipients. This study found IET significantly increases hospital mortality, highlighting the need for optimized antibiotic strategies in this vulnerable patient group.
Area of Science:
- Infectious Diseases
- Transplant Medicine
- Clinical Pharmacy
Background:
- Empiric antibiotic therapy is a common practice before definitive pathogen identification.
- Inadequate empiric therapy (IET), where initial antibiotics are not effective against the isolated organism, poses a clinical challenge.
- The incidence and impact of IET in solid-organ transplant (SOT) recipients remain largely uncharacterized.
Purpose of the Study:
- To determine the incidence of IET in SOT recipients.
- To investigate the clinical significance and impact of IET on hospital mortality in SOT patients.
- To identify factors associated with mortality in SOT patients receiving IET.
Main Methods:
- Retrospective cohort study design.
- Inclusion of SOT patients admitted between 2002 and 2004.
- Application of multiple logistic regression analyses to identify mortality determinants.
Main Results:
- IET was administered to 54% of the studied SOT patients.
- Hospital mortality was significantly higher in patients receiving IET (24.9%) compared to those with adequate therapy (7.0%).
- Factors independently correlated with increased hospital mortality included longer duration of IET, ICU-associated infections, prior antibiotic use, and higher APACHE-II scores.
Conclusions:
- Inadequate empiric therapy is prevalent in the SOT population.
- IET is associated with a substantially increased risk of hospital mortality in SOT recipients.
- These findings underscore the critical need for timely and effective empiric antibiotic selection in SOT patients to improve outcomes.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant III: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention